On October 22, WUXI APPTEC fell 3.32% in Regular Trading, trading at HK$189.3, with turnover of HK$497 million.
The latest market-moving catalyst is that the company is scheduled to hold a board meeting on October 26 to review its first three quarters results, while the broader Life Sciences Tools & Services group turned weaker, adding pressure to the shares.
Market expectations ahead of the report are relatively strong on revenue and earnings growth, with consensus pointing to quarterly revenue of RMB15.30 billion, up 34.65% year over year, EBIT of RMB6.717 billion, up 67.66%, and adjusted EPS of RMB1.81, up 77.71%. Even so, recent trading has shown mixed signals: institutional block trades on October 21 indicated net selling of RMB162 million, while earlier disclosures showed several global investors increasing H-share stakes this month. Those cross-currents appear to be intensifying short-term positioning into the results window.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments